{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T06:05:03Z","timestamp":1781849103338,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,9,18]],"date-time":"2011-09-18T00:00:00Z","timestamp":1316304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00228-011-1124-2","type":"journal-article","created":{"date-parts":[[2011,9,17]],"date-time":"2011-09-17T04:27:44Z","timestamp":1316233664000},"page":"311-319","source":"Crossref","is-referenced-by-count":18,"title":["Use of addictive anxiolytics and hypnotics in a national cohort of incident users in Norway"],"prefix":"10.1007","volume":"68","author":[{"given":"Svein R.","family":"Kjosavik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Ruths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steinar","family":"Hunskaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,18]]},"reference":[{"key":"1124_CR1","unstructured":"The Norwegian Institute of Public Health (2010) Addictive drugs. http:\/\/www.fhi.no\/dokumenter\/9f4576d31a.PDF"},{"key":"1124_CR2","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1046\/j.1360-0443.2003.00491.x","volume":"98","author":"G Hajak","year":"2003","unstructured":"Hajak G, Muller WE, Wittchen HU, Pittrow D, Kirch W (2003) Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 98:1371\u20131378","journal-title":"Addiction"},{"key":"1124_CR3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/pds.1763","volume":"18","author":"L Orriols","year":"2009","unstructured":"Orriols L, Salmi LR, Philip P, Moore N, Delorme B, Castot A, Lagarde E (2009) The impact of medicinal drugs on traffic safety: a systematic review of epidemiological studies. Pharmacoepidemiol Drug Saf 18:647\u2013658","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1124_CR4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00004714-200206000-00009","volume":"22","author":"S Paterniti","year":"2002","unstructured":"Paterniti S, Dufouil C, Alperovitch A (2002) Long-term benzodiazepine use and cognitive decline in the elderly: the epidemiology of vascular aging study. J Clin Psychopharmacol 22:285\u2013293","journal-title":"J Clin Psychopharmacol"},{"key":"1124_CR5","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/pds.2031","volume":"19","author":"K Zint","year":"2010","unstructured":"Zint K, Haefeli WE, Glynn RJ, Mogun H, Avorn J, Sturmer T (2010) Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults. Pharmacoepidemiol Drug Saf 19:1248\u20131255","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1124_CR6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/15622970802465807","volume":"9","author":"B Bandelow","year":"2008","unstructured":"Bandelow B, Zohar J, Hollander E, Kasper S, Moller HJ, Allgulander C, Ayuso-Gutierrez J, Baldwin DS, Buenvicius R, Cassano G, Fineberg N, Gabriels L, Hindmarch I, Kaiya H, Klein DF, Lader M, Lecrubier Y, Lepine JP, Liebowitz MR, Lopez-Ibor JJ, Marazziti D, Miguel EC, Oh KS, Preter M, Rupprecht R, Sato M, Starcevic V, Stein DJ, van Ameringen M, Vega J (2008) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders\u2014first revision. World J Biol Psychiatry 9:248\u2013312","journal-title":"World J Biol Psychiatry"},{"key":"1124_CR7","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jclp.20733","volume":"66","author":"DJ Taylor","year":"2010","unstructured":"Taylor DJ, Roane BM (2010) Treatment of insomnia in adults and children: a practice-friendly review of research. J Clin Psychol 66:1137\u20131147","journal-title":"J Clin Psychol"},{"key":"1124_CR8","unstructured":"World Health Organization (2009) Pharmacological treatment of mental disorders in primary health care. http:\/\/whqlibdoc.who.int\/publications\/2009\/9789241547697_eng.pdf"},{"key":"1124_CR9","unstructured":"Norwegian Board of Health Supervision (2001) Vanedannende legemidler, forskrivning og forsvarlighet. http:\/\/www.helsetilsynet.no\/upload\/Publikasjoner\/andrepublikasjoner\/vanedannende_legemidler_forskrivning_forsvarlighet_ik-2755.pdf"},{"key":"1124_CR10","unstructured":"Norwegian Medicines Agency (2000) Behandling av s\u00f8vnvansker. http:\/\/www.legemiddelverket.no\/upload\/76527\/publikasjon8-2000.pdf"},{"key":"1124_CR11","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0277-9536(96)00296-1","volume":"44","author":"D Isacson","year":"1997","unstructured":"Isacson D (1997) Long-term benzodiazepine use: factors of importance and the development of individual use patterns over time\u2014a 13-year follow-up in a Swedish community. Soc Sci Med 44:1871\u20131880","journal-title":"Soc Sci Med"},{"key":"1124_CR12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/pds.784","volume":"12","author":"R Hulten van","year":"2003","unstructured":"van Hulten R, Isacson D, Bakker A, Leufkens HG (2003) Comparing patterns of long-term benzodiazepine use between a Dutch and a Swedish community. Pharmacoepidemiol Drug Saf 12:49\u201353","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1124_CR13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/09540260500071863","volume":"17","author":"CI Neutel","year":"2005","unstructured":"Neutel CI (2005) The epidemiology of long-term benzodiazepine use. Int Rev Psychiatry 17:189\u2013197","journal-title":"Int Rev Psychiatry"},{"key":"1124_CR14","unstructured":"Norwegian Medicines Agency (2002) Flunitrazepam: legemidler som inneholder flunitrazepam omklassifiseres til reseptgruppe A fra 2003-01-01. http:\/\/www.slv.no\/templates\/InterPage_16527.aspx"},{"key":"1124_CR15","unstructured":"NOMESCO (2009) Medicines consumption in the Nordic countries 2004\u20132008. Nordic Medico Statistical Committee. http:\/\/nomesco-eng.nom-nos.dk\/filer\/publikationer\/Medicines%20consumption%202004-2008%20web.pdf"},{"key":"1124_CR16","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/pds.1756","volume":"18","author":"SR Kjosavik","year":"2009","unstructured":"Kjosavik SR, Ruths S, Hunskaar S (2009) Psychotropic drug use in the Norwegian general population in 2005: data from the Norwegian prescription database. Pharmacoepidemiol Drug Saf 18:572\u2013578","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1124_CR17","unstructured":"The Norwegian Institute of Public Health (2009) The Norwegian prescription database. http:\/\/www.norpd.no\/"},{"key":"1124_CR18","unstructured":"WHO Collaborating Center for Drug Statistics Methodology (2010) ATC \/ DDD index 2010. http:\/\/www.whocc.no\/atc_ddd_index\/"},{"key":"1124_CR19","unstructured":"The Ministry of Health and Care Services (2000) Regulation relating to a Municipal Regular GP Scheme. http:\/\/www.regjeringen.no\/en\/dep\/hod\/dok\/lover_regler\/reglement\/2000\/regulation-relating-to-a-municipal-regul.html?id=420530"},{"key":"1124_CR20","first-page":"652","volume":"124","author":"J Grytten","year":"2004","unstructured":"Grytten J, Skau I, Carlsen F (2004) Patient satisfaction with general practice services before and after the list patient reform. Tidsskr Nor Laegeforen 124:652\u2013654","journal-title":"Tidsskr Nor Laegeforen"},{"key":"1124_CR21","first-page":"358","volume":"124","author":"J Grytten","year":"2004","unstructured":"Grytten J, Skau I, Sorensen R, Aasland OG (2004) Physicians' work situation a year after the list patient system reform. Tidsskr Nor Laegeforen 124:358\u2013361","journal-title":"Tidsskr Nor Laegeforen"},{"key":"1124_CR22","unstructured":"Norwegian Social Science Data Services (2010) Data from the regular GP scheme, individual level data. http:\/\/www.nsd.uib.no\/nsd\/english\/individualdata.html"},{"key":"1124_CR23","unstructured":"Statistics Norway (2010) StatBank Norway. http:\/\/statbank.ssb.no\/\/statistikkbanken\/default_fr.asp?PLanguage=1"},{"key":"1124_CR24","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1600-0447.2011.01697.x","volume":"123","author":"SR Kjosavik","year":"2011","unstructured":"Kjosavik SR, Hunskaar S, Aarsland D, Ruths S (2011) Initial prescription of antipsychotics and antidepressants in general practice and specialist care in Norway. Acta Psychiatr Scand 123:459\u2013465","journal-title":"Acta Psychiatr Scand"},{"key":"1124_CR25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00228-002-0548-0","volume":"58","author":"R Hulten van","year":"2003","unstructured":"van Hulten R, Teeuw KB, Bakker A, Leufkens HG (2003) Initial 3-month usage characteristics predict long-term use of benzodiazepines: an 8-year follow-up. Eur J Clin Pharmacol 58:689\u2013694","journal-title":"Eur J Clin Pharmacol"},{"key":"1124_CR26","unstructured":"Norwegian Medicines Agency (2010) Referat fra m\u00f8te i bivirkningsnemda. http:\/\/www.legemiddelverket.no\/upload\/10-10305-2%20Referat%20fra%20m\u00f8te%20i%20Bivirkningsnemnda%2027052010%20endelig%201528979.pdf"},{"key":"1124_CR27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00228-008-0565-8","volume":"65","author":"AM Hausken","year":"2009","unstructured":"Hausken AM, Furu K, Skurtveit S, Engeland A, Bramness JG (2009) Starting insomnia treatment: the use of benzodiazepines versus z-hypnotics. A prescription database study of predictors. Eur J Clin Pharmacol 65:295\u2013301","journal-title":"Eur J Clin Pharmacol"},{"key":"1124_CR28","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4088\/JCP.v63n0912","volume":"63","author":"MM Ohayon","year":"2002","unstructured":"Ohayon MM, Lader MH (2002) Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry 63:817\u2013825","journal-title":"J Clin Psychiatry"},{"key":"1124_CR29","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00228-007-0341-1","volume":"63","author":"A Veronese","year":"2007","unstructured":"Veronese A, Garatti M, Cipriani A, Barbui C (2007) Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation. Eur J Clin Pharmacol 63:867\u2013873","journal-title":"Eur J Clin Pharmacol"},{"key":"1124_CR30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0277-9536(93)90018-Y","volume":"36","author":"D Isacson","year":"1993","unstructured":"Isacson D, Bingefors K, Wennberg M, Dahlstrom M (1993) Factors associated with high-quantity prescriptions of benzodiazepines in Sweden. Soc Sci Med 36:343\u2013351","journal-title":"Soc Sci Med"},{"key":"1124_CR31","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005650-199306000-00010","volume":"31","author":"M Olfson","year":"1993","unstructured":"Olfson M, Klerman GL (1993) Trends in the prescription of psychotropic medications. The role of physician specialty. Med Care 31:559\u2013564","journal-title":"Med Care"},{"key":"1124_CR32","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/jama.279.7.526","volume":"279","author":"HA Pincus","year":"1998","unstructured":"Pincus HA, Tanielian TL, Marcus SC, Olfson M, Zarin DA, Thompson J, Magno Zito J (1998) Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. JAMA 279:526\u2013531","journal-title":"JAMA"},{"key":"1124_CR33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/fampra\/14.5.361","volume":"14","author":"TB Dybwad","year":"1997","unstructured":"Dybwad TB, Kjolsrod L, Eskerud J, Laerum E (1997) Why are some doctors high-prescribers of benzodiazepines and minor opiates? A qualitative study of GPs in Norway. Fam Pract 14:361\u2013368","journal-title":"Fam Pract"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-011-1124-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-011-1124-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-011-1124-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T08:48:54Z","timestamp":1558687734000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-011-1124-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,18]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["1124"],"URL":"https:\/\/doi.org\/10.1007\/s00228-011-1124-2","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,18]]}}}